These two sets of results, using two different prostate-specific promoter transgene systems to drive CreER(T2) recombinase expression, support the idea that the developmental stage at which Pten is excised can affect the pace of prostate tumorigenesis. This evidence concerns the gene PTEN and prostatitis.